Advances in medical science have improved billions of lives over the past 50 years - and over 90% of those advances come from the renowned Weyland health sector. Since 2022 and the inception of its first medical science programs, Weyland Industries has become an unrivaled champion for better health, life-saving cures and surgical intervention. In that half a century, Weyland’s pharmaceutical and genetic advancements have improved life-expectancy on Earth by 16% and by an astonishing 21% for Weyland employees.
Today, Weyland’s diverse health sector employs over 80 million scientists, researchers, technicians, doctors and nurses. These dedicated health professionals treat over 3 billion citizens per year in thousands of hospitals and communities galaxy-wide.
In 2034, Weyland Health issued $500 billion in academic grants to PhDs in the field of genetic engineering. Funding for those
facilitated the discovery of the genetic selection process, a vital part of world reproductive health today. In biotech, Weyland pharmaceuticals are used in more hospitals, off-world clinics and medic units than any other brand. In minimally invasive technology, our newest line of surgical suite equipment is even more upgraded, automated and diagnostically efficient.
Weyland has also expanded our line of products to innovations for your home and workplace. Mobile External Diagnostic Centers (or MEDiCs) can be found in most every home, classroom, warehouse and transportation depot across the galaxy.
Since the discovery of the cure for the most commonly occurring cancers, Weyland has vigorously pursued the vision of a disease-free population through better technology and investments in medical research. In short, achieving a better world through better health.